Glatiramer and injection site necrosis Patient Reports February 11, 2012

Glatiramer Side Effects Report #4589633-X
Glatiramer side effect was reported by a Consumer or non-health professional from on Feb 02, 2005. Male patient, 55 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site erythema, injection site necrosis, injection site oedema, injection site pain, rash . Glatiramer dosage: 20 MILLIGRAM SUBCUTANEOUS. Patient recovered.

Glatiramer Side Effects Report #4686120-5
Glatiramer side effect was reported by a Consumer or non-health professional from on May 25, 2005. Male patient, 55 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site discolouration, injection site erythema, injection site haemorrhage, injection site induration, injection site necrosis, injection site oedema, injection site pain, lividity, scar . Glatiramer dosage: 20 MILLIGRAM, SUBCUTANEOUS. During the same period patient was treated with ASPIRIN, GINKGO TREE LEAVES, TESTOSTERONE. Patient recovered.

Glatiramer Side Effects Report #4594107-6
Glatiramer side effect was reported by a Consumer or non-health professional from on Feb 07, 2005. Female patient, 54 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site necrosis. Glatiramer dosage: 20 MILLIGRAM. Patient recovered.

Glatiramer Side Effects Report #4846993-X
Glatiramer side effect was reported by a Consumer or non-health professional from CANADA on Nov 22, 2005. Female patient, 52 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: abscess , contusion, eschar, injection site necrosis, lipoatrophy. Glatiramer dosage: 20 MILLIGRAM. During the same period patient was treated with BACLOFEN, GABAPENTIN, LEVOTHYROXINE, FLAVOXATE, VENLAFAXINE HYDROCHLORIDE, CONJUGATED ESTROGENS, DEXAMFETAMINE SULPHATE, RHOVANE. Patient recovered.


Glatiramer Side Effects Report #4796345-6
Glatiramer side effect was reported by a Consumer or non-health professional from CANADA on Sept 29, 2005. Female patient, 50 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site necrosis. Glatiramer dosage: 20 MILLIGRAM; SUBCUTANEOUS. During the same period patient was treated with BACLOFEN, LEVOTHYROXINE. Patient recovered.

Glatiramer Side Effects Report #4854954-X
Glatiramer side effect was reported by a Consumer or non-health professional from CANADA on Dec 06, 2005. Female patient, 50 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site necrosis. Glatiramer dosage: 20 MILLIGRAM, SUBCUTANEOUS. During the same period patient was treated with BACLOFEN, LEVOTHYROXINE, TRAZODONE, ATENOLOL. Patient recovered.

Glatiramer Side Effects Report #4854955-1
Glatiramer side effect was reported by a Consumer or non-health professional from CANADA on Dec 09, 2005. Male patient, 48 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site bruising, injection site necrosis, injection site pain, scab . Glatiramer dosage: 20 MILLIGRAM, ORAL. During the same period patient was treated with GABAPENTIN. Patient recovered.

Glatiramer Side Effects Report #4931256-4
Glatiramer side effect was reported by a Consumer or non-health professional from CANADA on Feb 21, 2006. Male patient, 48 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: burning sensation, contusion, injection site bruising, injection site necrosis, injection site pain. Glatiramer dosage: 20 MILLIGRAM. During the same period patient was treated with GABAPENTIN, AMITRIPTYLINE HYDROCHLORIDE, ATORVASTATIN CALCIUM. Patient recovered.

Glatiramer Side Effects Report #4968067-X
Glatiramer side effect was reported by a Consumer or non-health professional from GERMANY on Mar 25, 2006. Female patient, 48 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: cutaneous vasculitis, eosinophilia, injection site induration, injection site necrosis, injection site reaction, panniculitis, skin haemorrhage. Glatiramer dosage: 20 MILLIGRAM SUBCUTANEOUS. Patient recovered.


Glatiramer Side Effects Report #4899213-4
Glatiramer side effect was reported by a Consumer or non-health professional from CANADA on Jan 23, 2006. Female patient, 46 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site bruising, injection site necrosis, injection site pain, refusal of treatment by patient, skin necrosis. Glatiramer dosage: 20 MILLIGRAM. During the same period patient was treated with ALERTEC, CELEBREX, TOLTERODINE, VENLAFAXINE, GABAPENTIN, OXBUTYNIN, PAROXETINE HYDROCHLORIDE, TAMOXIFEN CITRATE. Patient recovered.

Glatiramer Side Effects Report #4866030-0
Glatiramer side effect was reported by a Consumer or non-health professional from NETHERLANDS on Dec 06, 2005. Female patient, 45 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site discolouration, injection site necrosis. Glatiramer dosage: 20 MILLIGRAM SUBCUTANEOUS. During the same period patient was treated with FAMPRIDINE, METOPROLOL. Patient recovered.

Glatiramer Side Effects Report #4885794-3
Glatiramer side effect was reported by a Consumer or non-health professional from NETHERLANDS on Jan 02, 2006. Female patient, 45 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: haematoma, injection site necrosis, loss of consciousness, open wound, post procedural complication. Glatiramer dosage: 20 MILLIGRAM. During the same period patient was treated with FAMPRIDINE, METOPROLOL, GABAPENTIN, TOLTERODINE TARTRATE, CONTRACEPTIVE. Patient recovered.

Glatiramer Side Effects Report #4677405-7
Glatiramer side effect was reported by a Consumer or non-health professional from on May 09, 2005. Female patient, 38 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: dizziness , hyperhidrosis, injection site necrosis, lipoatrophy. Glatiramer dosage: 20 MILLIGRAM SUBCUTANEOUS. Patient recovered.

Glatiramer Side Effects Report #4985785-8
Glatiramer side effect was reported by a Physician from GERMANY on Apr 06, 2006. Female patient, 33 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: contusion, dyspnoea, erythema, injection site abscess, injection site haematoma, injection site necrosis, injection site reaction, pain , scab . Glatiramer dosage: 20 MILLIGRAM. Patient recovered.


Glatiramer Side Effects Report #4664723-1
Glatiramer side effect was reported by a Consumer or non-health professional from on May 02, 2005. Female patient, 32 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site erythema, injection site haemorrhage, injection site necrosis, injection site swelling, procedural complication, purulence, scab , scar , scratch. Glatiramer dosage: 20 MILLIGRAM, SUBCUTANEOSU. Patient recovered.

Glatiramer Side Effects Report #4951013-2
Glatiramer side effect was reported by a Consumer or non-health professional from CANADA on Mar 07, 2006. Female patient, 29 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injected limb mobility decreased, injection site necrosis, injection site scar, lipoatrophy, skin discolouration. Glatiramer dosage: 20 MILLIGRAM; SUBCUTANEOUS. During the same period patient was treated with OXAZEPAM, CELEXA, BIRTH CONTROL, AMFEBUTAMONE HYDROCHLORIDE, KEPPRA, GLUCOSAMINE. Patient recovered.

Glatiramer Side Effects Report #4560765-5
Glatiramer side effect was reported by a Consumer or non-health professional from on Jan 17, 2005. Female patient, 28 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site induration, injection site necrosis. Glatiramer dosage: 20 MILLIGRAM SUBCUTANEOUS. Patient recovered.

Glatiramer Side Effects Report #5044591-9
Glatiramer side effect was reported by a Consumer or non-health professional from SPAIN on June 23, 2006. Male patient, 28 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: embolia cutis medicamentosa, injection site induration, injection site necrosis. Glatiramer dosage: 20 MILLIGRAM, SUBCUTANEOUS. Patient recovered.

Glatiramer Side Effects Report #4823613-1
Glatiramer side effect was reported by a Consumer or non-health professional from GERMANY on Oct 27, 2005. Female patient, 27 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: dizziness , injection site bruising, injection site discolouration, injection site haemorrhage, injection site infection, injection site necrosis, injection site scar, skin necrosis. Glatiramer dosage: 20 MILLIGRAM. During the same period patient was treated with MONOSTEP. Patient recovered.


Glatiramer Side Effects Report #4863928-4
Glatiramer side effect was reported by a Physician from GERMANY on Dec 06, 2005. Female patient, 27 years of age, was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: contusion, dizziness , infection , injection site bruising, injection site discolouration, injection site haemorrhage, injection site infection, injection site necrosis, injection site scar. Glatiramer dosage: 20 MILLIGRAM SUBCUTANEOUS. During the same period patient was treated with MONOSTEP. Patient recovered.

Glatiramer Side Effects Report #4564564-X
Glatiramer side effect was reported by a Consumer or non-health professional from on Jan 18, 2005. Female patient was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site necrosis. Glatiramer dosage: 20 MILLIGRAM. Patient recovered.

Glatiramer Side Effects Report #4848593-4
Glatiramer side effect was reported by a Consumer or non-health professional from GERMANY on Nov 23, 2005. Female patient was diagnosed with multiple sclerosis  and was treated with Glatiramer. After drug was administered, patient experienced the following side effects: injection site necrosis. Glatiramer dosage: 20 MILLIGRAM. Patient recovered.

Glatiramer Side Effects Report #4686121-7
Glatiramer side effect was reported by a Physician from on May 26, 2005. Male patient, 41 years of age, was treated with Glatiramer. After drug was administered, patient experienced the following side effects: abdominal pain , injection site erythema, injection site necrosis, injection site pain, injection site vesicles, muscle spasms, rash vesicular. Glatiramer dosage: 20 MILLIGRAM, SUBCUTANEOUS. During the same period patient was treated with MICARDIS, ZOLPIDEM. Patient was hospitalized. Patient recovered.